Abstract
Sodium glucose co-transporter 2 (SGLT2) inhibitors lower blood pressure by osmotic diuresis and can be considered in diabetic patients with resistant hypertension.
Original language | English |
---|---|
Number of pages | 3 |
Journal | JRSM Open |
Volume | 7 |
Issue number | 9 |
DOIs | |
Publication status | Published - 1 Sept 2016 |
Keywords
- SGLT2 inhibitor
- canagliflozin
- resistant hypertension
- diabetes
- obesity